EMOTIVE BOSTON, USA, Monday 18th July, 2022 – Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that the National Institute for Health and Care Excellence (NICE) has issued guidance...
Tag: <span>treating obesity</span>
Post
Study finds targeting mitochondria shows promise in treating obesity
by University of California, Irvine Credit: CC0 Public Domain A team of University of California, Irvine, scientists have discovered a novel pharmacological approach to attenuate the mitochondrial dysfunction that drives diet-induced obesity. The results of their study were published recently in the journal, EMBO Molecular Medicine. Consuming a high-fat diet can lead to obesity and metabolic disorders...
Post
Boosting body heat production: A new approach for treating obesity
GARVAN INSTITUTE OF MEDICAL RESEARCH IMAGE: CO-SENIOR AUTHOR DR YAN-CHUAN SHI CREDIT: GARVAN INSTITUTE A receptor that helps conserve energy when food is scarce may be the key to a safer approach to treating diet-induced obesity, research led by the Garvan Institute of Medical Research has revealed. In a study using experimental models and fat tissue biopsies from obese individuals,...